Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies in the pharmaceutical industry. This partnership aims to develop health services and enhance health awareness among citizens and residents in the Kingdom of Saudi Arabia.
The agreement focuses primarily on exchanging expertise and developing human capabilities in the health sector. Through this collaboration, both parties seek to provide specialized training programs for medical staff, which will contribute to increasing the efficiency of services provided to patients in the Jeddah Health Cluster facilities.
In addition to the training aspect, the agreement includes initiatives to spread health awareness among community members. Jamjoom Pharma will work with Jeddah Health Cluster Two to organize awareness campaigns on common diseases and methods of prevention, in support of the Kingdom's Vision 2030 to improve the quality of healthy life.
This step comes within the framework of the Saudi Ministry of Health's efforts to strengthen the partnership between the public and private sectors. It is expected that this initiative will contribute to improving the patient experience and providing innovative pharmaceutical solutions and health services that comply with the highest international standards.
In conclusion, this cooperation reflects the commitment of national institutions in the Kingdom to work together to develop health infrastructure. The results of this partnership are expected to appear in a tangible improvement in the level of healthcare and awareness services provided in the city of Jeddah during the coming period.